基本信息
浏览量:3
职业迁徙
个人简介
Research interests
Congenital heart disease (CHD) is one of the most common birth defects, with an incidence of 75/1000 live births internationally. Advances in surgical and medical care of CHD in children have led to growth in the number of adults living with CHD, especially those with complex heart disease. The changing epidemiology of the CHD population has created a need for improved specialty care for these patients. Professor Celermajer’s team conducts research in both clinical science and public health to help inform clinical treatment and policy concerning adults with CHD.
David led the development of the Adult Congenital Heart Disease (ACHD) Database at Royal Prince Alfred Hospital, an essential tool in the clinical care and research of NSW’s largest ACHD population. Specifically, this has enabled research into the characterisation and management of late stage complications in ACHD, such as pulmonary hypertension, arrhythmias, endocarditis and heart failure. Professor Celermajer’s research also investigates CHD’s impact on other systems in the body, for example, retinal vessel changes in the adults with Coarctation of the Aorta. Appropriate exercise has also been a key focus on improving the outcomes in ACHD patients, particularly in individuals living with a Fontan circulation.
From a public health perspective, his research group is interested in developing ‘whole-of-life’ care for patients with CHD. Previous research from his group shows that patients require continuing follow up with specialty CHD clinicians to minimise risk of late stage complications associated with ACHD. Based on these findings, David’s group has begun to collaborate with various NSW Health districts to demonstrate a model that will provide system-wide ‘whole-of-life’ care for patients with CHD.
Congenital heart disease (CHD) is one of the most common birth defects, with an incidence of 75/1000 live births internationally. Advances in surgical and medical care of CHD in children have led to growth in the number of adults living with CHD, especially those with complex heart disease. The changing epidemiology of the CHD population has created a need for improved specialty care for these patients. Professor Celermajer’s team conducts research in both clinical science and public health to help inform clinical treatment and policy concerning adults with CHD.
David led the development of the Adult Congenital Heart Disease (ACHD) Database at Royal Prince Alfred Hospital, an essential tool in the clinical care and research of NSW’s largest ACHD population. Specifically, this has enabled research into the characterisation and management of late stage complications in ACHD, such as pulmonary hypertension, arrhythmias, endocarditis and heart failure. Professor Celermajer’s research also investigates CHD’s impact on other systems in the body, for example, retinal vessel changes in the adults with Coarctation of the Aorta. Appropriate exercise has also been a key focus on improving the outcomes in ACHD patients, particularly in individuals living with a Fontan circulation.
From a public health perspective, his research group is interested in developing ‘whole-of-life’ care for patients with CHD. Previous research from his group shows that patients require continuing follow up with specialty CHD clinicians to minimise risk of late stage complications associated with ACHD. Based on these findings, David’s group has begun to collaborate with various NSW Health districts to demonstrate a model that will provide system-wide ‘whole-of-life’ care for patients with CHD.
研究兴趣
论文共 139 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE (2024): 100490
Pediatric Cardiologyno. 3 (2024): 529-543
Heart, Lung and Circulation (2023): S252-S253
引用0浏览0引用
0
0
Physiological Reportsno. 1 (2023)
引用1浏览0WOS引用
1
0
International Journal of Cardiology Congenital Heart Disease (2023): 100427-100427
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn